316 related articles for article (PubMed ID: 16455623)
21. Radioimmunotherapy of prostate cancer.
Smith-Jones PM
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):297-304. PubMed ID: 15640793
[TBL] [Abstract][Full Text] [Related]
22. Pretargeting with the affinity enhancement system for radioimmunotherapy.
Barbet J; Kraeber-Bodéré F; Vuillez JP; Gautherot E; Rouvier E; Chatal JF
Cancer Biother Radiopharm; 1999 Jun; 14(3):153-66. PubMed ID: 10850300
[TBL] [Abstract][Full Text] [Related]
23. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
[TBL] [Abstract][Full Text] [Related]
24. Antibody-based cancer therapies: back to "polyclonals"?
Paganelli G; De Santis R
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1453-5. PubMed ID: 15258701
[No Abstract] [Full Text] [Related]
25. Pretargeted radioimmunotherapy.
Meredith RF; Buchsbaum DJ
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S57-9. PubMed ID: 16979441
[TBL] [Abstract][Full Text] [Related]
26. Treatment of infection with radiolabeled antibodies.
Dadachova E; Casadevall A
Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):193-204. PubMed ID: 16868533
[TBL] [Abstract][Full Text] [Related]
27. Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends.
Steiner M; Neri D
Clin Cancer Res; 2011 Oct; 17(20):6406-16. PubMed ID: 22003068
[TBL] [Abstract][Full Text] [Related]
28. Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.
Chang CH; Sharkey RM; Rossi EA; Karacay H; McBride W; Hansen HJ; Chatal JF; Barbet J; Goldenberg DM
Mol Cancer Ther; 2002 May; 1(7):553-63. PubMed ID: 12479274
[TBL] [Abstract][Full Text] [Related]
29. Advances in radioimmunotherapy in the age of molecular engineering and pretargeting.
Sharkey RM; Goldenberg DM
Cancer Invest; 2006 Feb; 24(1):82-97. PubMed ID: 16466997
[TBL] [Abstract][Full Text] [Related]
30. Candidates for peptide receptor radiotherapy today and in the future.
Reubi JC; Mäcke HR; Krenning EP
J Nucl Med; 2005 Jan; 46 Suppl 1():67S-75S. PubMed ID: 15653654
[TBL] [Abstract][Full Text] [Related]
31. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810
[TBL] [Abstract][Full Text] [Related]
32. Radionuclide therapy of cancer with radiolabeled antibodies.
Boerman OC; Koppe MJ; Postema EJ; Corstens FH; Oyen WJ
Anticancer Agents Med Chem; 2007 May; 7(3):335-43. PubMed ID: 17504159
[TBL] [Abstract][Full Text] [Related]
33. Cell-penetrating peptides and antibodies: a new direction for optimizing radioimmunotherapy.
Jain M; Venkatraman G; Batra SK
Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):973-7. PubMed ID: 17453198
[No Abstract] [Full Text] [Related]
34. Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
Kraeber-Bodéré F; Rousseau C; Bodet-Milin C; Ferrer L; Faivre-Chauvet A; Campion L; Vuillez JP; Devillers A; Chang CH; Goldenberg DM; Chatal JF; Barbet J
J Nucl Med; 2006 Feb; 47(2):247-55. PubMed ID: 16455630
[TBL] [Abstract][Full Text] [Related]
35. Pretargeting: A Path Forward for Radioimmunotherapy.
Cheal SM; Chung SK; Vaughn BA; Cheung NV; Larson SM
J Nucl Med; 2022 Sep; 63(9):1302-1315. PubMed ID: 36215514
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunotherapy. Progress, potential and problems.
Mather SJ; Britton KE
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):248-50. PubMed ID: 15640787
[No Abstract] [Full Text] [Related]
37. The direct route may not be the best way to home.
Sharkey RM
J Nucl Med; 2005 Mar; 46(3):391-4. PubMed ID: 15750148
[No Abstract] [Full Text] [Related]
38. Outpatient administration of radiolabeled monoclonal antibodies.
Tuinstra N
Clin J Oncol Nurs; 2003; 7(1):106-8. PubMed ID: 12629945
[No Abstract] [Full Text] [Related]
39. Antibody-guided radiation therapy of cancer.
Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
[TBL] [Abstract][Full Text] [Related]
40. Radioimmunodetection and therapy of breast cancer.
DeNardo SJ
Semin Nucl Med; 2005 Apr; 35(2):143-51. PubMed ID: 15765377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
